Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase 3 4 Phase 4 2 Phase 1 1

Status

Completed 15 Unknown 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 57 Breast Neoplasms 52 Leukemia, Myeloid, Acute 40 Carcinoma, Non-Small-Cell Lung 40 Lymphoma 35 Pancreatic Neoplasms 30 Leukemia, Lymphocytic, Chronic, B-Cell 30 Leukemia 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Neoplasm Metastasis 27 Ovarian Neoplasms 25 Multiple Myeloma 25 Lymphoma, Non-Hodgkin 25 Recurrence 24 Lung Neoplasms 23 Melanoma 22 Lymphoma, Large B-Cell, Diffuse 21 Prostatic Neoplasms 20 Glioblastoma 20 Brain Neoplasms 19 Colorectal Neoplasms 18 Lymphoma, Follicular 17 Squamous Cell Carcinoma of Head and Neck 16 Sarcoma 16 Lymphoma, B-Cell 15 Lymphoma, Mantle-Cell 14 Myelodysplastic Syndromes 13 Urinary Bladder Neoplasms 12 Lymphoma, B-Cell, Marginal Zone 12 Glioma 12

Interventions

Letrozole 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × Leiomyoma × Clear all

NCT00945360 2012-07-13

Aromatase Inhibitors for Treatment of Uterine Leiomyomas

American University of Beirut Medical Center

Phase 1 Withdrawn

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡